Atlas Trials

Myeloma, Plasma-Cell

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myeloma, Plasma-Cell

RecordFirmDate
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330)Biomea Fusion Inc.2022-01-24
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma (NCT04782687)US Oncology Research2021-09-10
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma (NCT03602612)National Cancer Institute (NCI)2018-09-14
Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients (NCT04065789)Tel-Aviv Sourasky Medical Center2018-05-02
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma (NCT02215967)National Cancer Institute (NCI)2014-08-12
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma (NCT01239368)National Cancer Institute (NCI)2010-11-10
Multi-day Doses in Prevention of Nausea and Emesis (NCT00600353)University of Kansas Medical Center2007-10-01
Phase I/II Study of hLL1 in Multiple Myeloma (NCT00421525)Gilead Sciences2007-01-01
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood (NCT00146055)University of Michigan Rogel Cancer Center2000-03-01

Track Myeloma, Plasma-Cell automatically

Every clearance here is in the API, with alerts when new ones post.